Wealth Enhancement Advisory Services, LLC Vertex Pharmaceuticals Inc Transaction History

Wealth Enhancement Advisory Services, LLC

$44.5 Billion
Q3 2024

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 101,891 shares of VRTX stock, worth $41.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

101,891

Previous 85,612 19.01%

Holding current value

$41.6 Million

Previous $40.1 Million 18.09%

% of portfolio

0.11%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$460.0 - $505.78 $7.49 Million - $8.23 Million	16,279 Added 19.01%	101,891 $47.4 Million
Q2 2024 Jul 16, 2024	BUY	$392.81 - $485.53 $1.4 Million - $1.74 Million	3,576 Added 4.36%	85,612 $40.1 Million
Q1 2024 Apr 15, 2024	BUY	$407.69 - $446.08 $2.88 Million - $3.15 Million	7,061 Added 9.42%	82,036 $34.3 Million
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $9.39 Million - $11.2 Million	27,386 Added 57.55%	74,975 $30.5 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $12.7 Million - $13.7 Million	37,677 Added 380.12%	47,589 $16.5 Million
Q2 2023 Jul 21, 2023	BUY	$314.42 - $351.91 $42,132 - $47,155	134 Added 1.37%	9,912 $3.49 Million
Q1 2023 Apr 25, 2023	BUY	$283.23 - $323.1 $23,791 - $27,140	84 Added 0.87%	9,778 $3.08 Million
Q4 2022 Feb 01, 2023	SELL	$285.76 - $321.48 $1.01 Million - $1.13 Million	-3,525 Reduced 26.67%	9,694 $2.8 Million
Q3 2022 Oct 17, 2022	BUY	$273.83 - $305.53 $3.62 Million - $4.04 Million	13,219 New	13,219 $3.9 Million
Q2 2022 Jul 18, 2022	SELL	$234.96 - $292.55 $5.37 Million - $6.69 Million	-22,874 Closed	0 $0
Q1 2022 Apr 18, 2022	BUY	$221.42 - $260.97 $184,000 - $216,866	831 Added 3.77%	22,874 $6.15 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $3.9 Million - $4.93 Million	22,043 New	22,043 $5.37 Million
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $1.43 Million - $1.91 Million	-6,920 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $1.42 Million - $1.68 Million	-5,547 Reduced 44.49%	6,920 $1.9 Million
Q2 2020 Oct 13, 2020	BUY	$225.48 - $295.8 $2.81 Million - $3.69 Million	12,467 New	12,467 $3.63 Million
Q1 2019 Apr 30, 2019	SELL	$163.73 - $194.7 $1.2 Million - $1.43 Million	-7,325 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$151.91 - $192.21 $1.11 Million - $1.41 Million	7,325 New	7,325 $1.43 Million
Q4 2017 Jan 19, 2018	SELL	$137.28 - $155.55 $784,692 - $889,123	-5,716 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$148.13 - $162.24 $846,711 - $927,363	5,716	5,716 $887,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Vertex Pharmaceuticals Inc Transaction History